NOVT:NSD-Novanta Inc (USD)

COMMON STOCK | Scientific & Technical Instruments |

Last Closing

USD 119.74

Change

-0.81 (-0.67)%

Market Cap

USD 3.74B

Volume

0.12M

Analyst Target

USD 109.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-25 )

Largest Industry Peers for Scientific & Technical Instruments

Symbol Name Price(Change) Market Cap
TRMB Trimble Inc

+0.06 (+0.10%)

USD 16.10B
CGNX Cognex Corporation

+0.07 (+0.27%)

USD 5.08B
ITRI Itron Inc

+1.25 (+1.15%)

USD 4.32B
MKSI MKS Instruments Inc

-0.05 (-0.07%)

USD 4.07B
ITRN Ituran Location and Control Lt..

+0.09 (+0.26%)

USD 0.65B
MLAB Mesa Laboratories Inc

+0.16 (+0.14%)

USD 0.65B
FARO FARO Technologies Inc

+0.23 (+0.74%)

USD 0.45B
MVIS Microvision Inc

N/A

USD 0.33B
SOTK Sono-Tek Corp

-0.11 (-2.72%)

USD 0.06B
MIND Mind Technology Inc

-0.02 (-0.31%)

USD 0.04B

ETFs Containing NOVT

LADR:XETRA 3.32 % 0.00 %

N/A

N/A
ROBO:SW L&G ROBO Global Robotics .. 1.61 % 0.00 %

+0.46 (+2.82%)

N/A
ROBO:AU ETFS ROBO Global Robotics.. 1.60 % 0.00 %

N/A

USD 0.25B
ROBE:LSE L&G ROBO Global Robotics .. 0.00 % 0.00 %

+0.23 (+2.82%)

USD 0.62B
ROBG:LSE L&G ROBO Global Robotics .. 0.00 % 0.00 %

+21.25 (+2.82%)

USD 0.62B
ROBO:LSE L&G ROBO Global Robotics .. 0.00 % 0.00 %

+0.29 (+2.82%)

USD 0.62B
IROB:F Legal & General UCITS ETF.. 0.00 % 0.00 %

+0.61 (+2.82%)

N/A
IROB:XETRA L&G ROBO Global Robotics .. 0.00 % 0.00 %

+0.26 (+2.82%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Scientific & Technical Instruments) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.62% 21% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.62% 21% F 32% F
Trailing 12 Months  
Capital Gain -24.89% 42% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.89% 42% F 34% F
Trailing 5 Years  
Capital Gain 44.04% 69% C- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.04% 69% C- 55% F
Average Annual (5 Year Horizon)  
Capital Gain 18.88% 89% A- 76% C+
Dividend Return 18.88% 84% B 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 52.44% 37% F 35% F
Risk Adjusted Return 36.01% 89% A- 69% C-
Market Capitalization 3.74B 76% C+ 87% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.